News

Switzerland is often perceived as a “small market” – which sometimes leads to one of two extremes: being deprioritised, or being overengineered from day one. Based on our experience, successful rare disease launches in Switzerland are not about size or complexity, but about making the right decisions at the right time. A smart entry to the Swiss market takes a holistic view and considers: Swissmedic regulatory requirements market access pathways and reimbursement strategy lea

The number of clients that have placed their confidence in Swizzard has grown steadily over the past five years. Today, we’re proud to have worked with 40 visionary biotech and pharma companies as they navigate the Swiss landscape. As momentum picks up and Swizzard’s client base continues to grow, our role is unchanged: we’re committed to bringing decision-ready insights, pragmatic options, strategic advice and measurable results. From market shaping and access planning to la

We’re celebrating five years of Swizzard! Swizzard was founded at the beginning of 2021 with a clear ambition: to help bring medical breakthroughs to Swiss patients. Today, we’re proud of what we’ve achieved thanks to our innovative clients and an exceptional team. Together, we’ve helped 39 biotech companies establish and grow their Swiss presence, advancing innovations across oncology, metabolism, dermatology, neurology and beyond, with a strong focus on rare diseases. Alo

Swizzard Pharma AG, a solution provider that supports biotech and pharma companies in successfully entering and thriving in the Swiss market, welcomes Philipp Heider as Medical & Market Access Associate Director. Philipp holds a Master of Science in Biotechnology from the Management Center Innsbruck and recently completed a CAS in Digital Life Sciences at Zurich University of Applied Sciences (ZHAW). His academic profile is complemented by certifications in Good Clinical Pra

As the year comes to an end, we took a moment to gather with our team and valued partners for a festive evening filled with reflection, gratitude, and shared achievements. It was a wonderful opportunity to celebrate the strong sense of collaboration that defines our work. For us, the holiday season is about more than festivities — it’s about giving back and creating meaningful connections. We’re honored to continue supporting CO-OPERAID for the fourth year in a row, helping y

Reverse Mentoring at Swizzard Pharma – Learning from the Next Generation At Swizzard Pharma, we believe learning is not a one-way street. Our students not only bring fresh knowledge from law, business, IT, and design, but also inspire us “experienced” professionals every day with new perspectives and digital skills. An example? Our students show us how to use AI tools effectively in daily work—whether for data analysis, visualizing complex relationships, or automating routine